Buprenorphine transdermal skin patch and Ibritumomab Tiuxetan
Determining the interaction of Buprenorphine transdermal skin patch and Ibritumomab Tiuxetan and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Ibrutinib
- Buprenorphine transdermal skin patch-Ibrutinib Capsules
- Buprenorphine transdermal skin patch-Ibrutinib Tablets
- Buprenorphine transdermal skin patch-Ibu
- Buprenorphine transdermal skin patch-IBU Tablets
- Buprenorphine transdermal skin patch-Ibu-2
- Ibritumomab Tiuxetan-Buprenorphine, Buprenorphine Hydrochloride
- Ibritumomab Tiuxetan-Buprenorphine/naloxone Oromucosal, Sublingual
- Ibritumomab Tiuxetan-Buproban
- Ibritumomab Tiuxetan-Bupropion
- Ibritumomab Tiuxetan-Bupropion and naltrexone
- Ibritumomab Tiuxetan-Bupropion Extended-Release Tablets